Xiaoling Wu
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
-
- Circular RNAs in diseases
- RNA modifications and cancer
- Epigenetics and DNA Methylation
- RNA Research and Splicing
- Cancer-related gene regulation
Papers in
-
- Cancer-related molecular mechanisms research 15
- MicroRNA in disease regulation 10
-
- RNA modifications and cancer 12
- Circular RNAs in diseases 7
- Epigenetics and DNA Methylation 7
- RNA Research and Splicing 6
- Cancer-related gene regulation 5
- Co-authors
- Dongge Cai (3 shared papers)Yidong Wang (4 shared papers)Bo Ning (2 shared papers)Xia Zhang (2 shared papers)Jinjun Guo (2 shared papers)Bo Liu (2 shared papers)Hongbin Zhang (1 shared paper)Zhenzhen Zhang (1 shared paper)
- Journals
- Oncology Reports (4 papers)PLoS ONE (3 papers)American Journal of Cancer Research (2 papers)Cancer Management and Research (2 papers)Cell Death Discovery (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Xiaoling Wu
50 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 83
- Cancer Research 481
- Molecular Biology 669
- Oncology 136
- Immunology 66
- Neurology 37
Countries citing papers authored by Xiaoling Wu
This map shows the geographic impact of Xiaoling Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoling Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoling Wu more than expected).
Fields of papers citing papers by Xiaoling Wu
This network shows the impact of papers produced by Xiaoling Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoling Wu. The network helps show where Xiaoling Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoling Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 164 | |
| 2 | 2014 | 74 | |
| 3 | 2017 | 48 | |
| 4 | 2014 | 47 | |
| 5 | 2015 | 46 | |
| 6 | 2021 | 34 | |
| 7 | 2023 | 34 | |
| 8 | 1999 | 33 | |
| 9 | 2020 | 32 | |
| 10 | 2018 | 31 | |
| 11 | Gamma-radiation-induced G2 delay, apoptosis, and p53 response as potential susceptibility markers for lung cancer. | 2001 | 30 |
| 12 | 2020 | 28 | |
| 13 | 2017 | 27 | |
| 14 | 2020 | 26 | |
| 15 | 2020 | 26 | |
| 16 | 2019 | 25 | |
| 17 | 2019 | 25 | |
| 18 | 2023 | 25 | |
| 19 | 2014 | 23 | |
| 20 | 2017 | 23 |
About Xiaoling Wu
Xiaoling Wu is a scholar working on Cancer Research, Molecular Biology, Oncology, Biochemistry and Reproductive Medicine, having authored 51 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (15 papers), RNA modifications and cancer (12 papers), MicroRNA in disease regulation (10 papers), Circular RNAs in diseases (7 papers), Epigenetics and DNA Methylation (7 papers), RNA Research and Splicing (6 papers), Cancer-related gene regulation (5 papers) and Cancer-related Molecular Pathways (3 papers). The work is most often cited by research in Cancer Research (481 citations), Molecular Biology (669 citations), Oncology (136 citations), Immunology (66 citations) and Neurology (37 citations). Xiaoling Wu has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Dongge Cai, Yidong Wang, Bo Ning, Xia Zhang, Jinjun Guo, Bo Liu, Hongbin Zhang, Zhenzhen Zhang, Yanmin Liu and Lulu Wang. Their work appears in journals such as Oncology Reports, PLoS ONE, American Journal of Cancer Research, Cancer Management and Research and Cell Death Discovery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.